ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

QSP postdoctoral scientist at Eli Lilly and Company - ApplyBlast

QSP postdoctoral scientist

Eli Lilly and Company

3 months ago

4.0 on Glassdoor

Boston, MA

Onsite

Full Time

Senior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

A Postdoctoral Scientist at Eli Lilly's Global PKPD group develops Quantitative Systems Pharmacology (QSP) models to drive decisions in drug discovery and development. This role involves designing ODE-based model structures, performing parameter estimation, and applying validated models to generate insights for dosing strategies and clinical development. The scientist collaborates with cross-functional teams to communicate modeling results and author peer-reviewed scientific articles.

Responsibilities

Design and implement ODE-based QSP model structures for biological systems
Perform parameter estimation and model simulations to inform drug development
Apply validated models to generate quantitative insights for dosing strategies
Communicate modeling results to technical and non-technical audiences
Author high-quality peer-reviewed scientific articles

Skills

Qualifications

PhD in quantitative pharmacology, systems biology, biomedical engineering, applied mathematics or related discipline

About Eli Lilly and Company

lilly.com

Headquarters

Indianapolis, Indiana, United States

Company Size

10001+ employees

Founded

1876

View Profile

Eli Lilly and Company is a global biopharmaceutical company headquartered in Indianapolis, Indiana. It discovers, develops, manufactures and commercializes prescription medicines across therapeutic areas including diabetes, oncology, immunology, neuroscience and pain, and has a longstanding history in insulin and other major drug discoveries. Lilly invests heavily in research and clinical development and partners with biotech, academic institutions, and industry collaborators to advance biologics, small molecules, and precision medicines. The company operates global manufacturing and commercial networks and provides patient-support programs to improve access to its therapies.